(Washington, DC – October 7, 2014) – The American College of Cardiology has appointed Galileo Analytics Co-Founder Anna McCollister-Slipp to serve on the Stakeholder Advisory Panel of its newly created Diabetes Collaborative Registry.

The Diabetes Collaborative Registry™ is the first global, cross-specialty, clinical diabetes registry designed to track and improve the quality of diabetes and metabolic care across the primary care and specialty care continuum.

The American College of Cardiology (ACC) and AstraZeneca, in partnership with the American Diabetes Association, American College of Physicians, and the Joslin Diabetes Center have joined forces to integrate compelling, data-rich assets to provide a unique, longitudinal view into the patient journey for those with diabetes and, ultimately, one day be able to transform the future of diabetes care.

The unique, real-world collaboration among multi-disciplinary providers is designed to help transform the future of diabetes treatment and prevention and improve the lives of billions.

The Stakeholder Advisory Panel panel includes representatives from physician organizations, academic researchers, advocacy groups, data analytics experts and diabetes patients. Panel members include:

William J. Oetgen, M.D., M.B.A., F.A.C.C., American College of Cardiology

Jane L. Chiang, M.D. , American Diabetes Association

Laura Lee Hall, Ph.D. , American College of Physicians

Catherine Carver, M.S., A.N.P., C.D.E., Joslin Diabetes Center

Anna McCollister-Slipp, Galileo Analytics

Gregory A. Nichols, Ph.D., M.B.A., F.A.H.A., Kaiser Permanente Center for Health Research

John W. Kennedy, M.D., Geisinger Health System

David C. Klonoff, M.D., F.A.C.P., F.R.C.P (Edin), Fellow AIMBE, Mills-Peninsula Health Services, Journal of Diabetes Science & Technology

Gary Puckrein, Ph.D., National Minority Quality Forum

Brian Anderson, M.D., athenaHealth

Jennifer Covich Bordenick, eHealth Initiative

Sandra Leonard, M.P.H., AstraZeneca

Javier Jimenez, M.D., M.P.H., AstraZeneca

William S. Cook, Ph.D., AstraZeneca

Iftekhar Kalsekhar, Ph.D., AstraZeneca

Mikhail Kosiborod, M.D., F.A.C.C., F.A.H.A., Saint Luke’s Mid America Heart Institute

Silvio Inzucchi, M.D., Yale Diabetes Center

Jennifer L. Wong, M.P.P., American College of Cardiology

More information about the Diabetes Collaborative Registry can be found at http://www.ncdr.com.